These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23521603)

  • 1. Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancer.
    Vergati M; Della-Morte D; Ferroni P; Cereda V; Tosetto L; La Farina F; Guadagni F; Roselli M
    Rejuvenation Res; 2013 Jun; 16(3):224-31. PubMed ID: 23521603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chemotherapy on activated protein C-dependent thrombin generation--association with VTE occurrence.
    Roselli M; Ferroni P; Riondino S; Mariotti S; Laudisi A; Vergati M; Cavaliere F; Palmirotta R; Guadagni F
    Int J Cancer; 2013 Sep; 133(5):1253-8. PubMed ID: 23404208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism risk prediction in ambulatory cancer patients: clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
    Ferroni P; Riondino S; Formica V; Cereda V; Tosetto L; La Farina F; Valente MG; Vergati M; Guadagni F; Roselli M
    Int J Cancer; 2015 Mar; 136(5):1234-40. PubMed ID: 25042739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.
    Kuderer NM; Culakova E; Lyman GH; Francis C; Falanga A; Khorana AA
    Oncologist; 2016 Jul; 21(7):861-7. PubMed ID: 27125754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy - a cohort study.
    Zahir MN; Shaikh Q; Shabbir-Moosajee M; Jabbar AA
    BMC Cancer; 2017 Jan; 17(1):57. PubMed ID: 28093087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
    Khorana AA; Dalal M; Lin J; Connolly GC
    Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in patients with cholangiocarcinoma: focus on risk factors and impact on survival.
    Jeon HK; Kim DU; Baek DH; Ha DW; Lee BE; Ryu DY; Cheong JH; Kim GH; Song GA; Jang AL
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):444-9. PubMed ID: 22410715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE.
    Yhim HY; Jang MJ; Kwak JY; Yim CY; Choi WI; Lee YC; Lee JO; Lee KW; Bang SM; Kim SH; Kim YK; Chang HJ; Oh D;
    Thromb Res; 2013 Apr; 131(4):e133-40. PubMed ID: 23399441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients.
    Piran S; Ngo V; McDiarmid S; Le Gal G; Petrcich W; Carrier M
    Thromb Res; 2014 Jan; 133(1):30-3. PubMed ID: 24188799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients.
    Ferroni P; Martini F; Portarena I; Massimiani G; Riondino S; La Farina F; Mariotti S; Guadagni F; Roselli M
    Clin Lung Cancer; 2012 Nov; 13(6):482-7. PubMed ID: 22591606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.
    Agnelli G; George DJ; Kakkar AK; Fisher W; Lassen MR; Mismetti P; Mouret P; Chaudhari U; Lawson F; Turpie AG;
    N Engl J Med; 2012 Feb; 366(7):601-9. PubMed ID: 22335737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients.
    Ferroni P; Palmirotta R; Riondino S; De Marchis ML; Nardecchia A; Formica V; Guadagni F; Roselli M
    Thromb Haemost; 2016 Jan; 115(1):143-51. PubMed ID: 26336029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy.
    Ferroni P; Guadagni F; Laudisi A; Vergati M; Riondino S; Russo A; Davì G; Roselli M
    Oncologist; 2014 May; 19(5):562-7. PubMed ID: 24710308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
    Khorana AA; Francis CW; Culakova E; Lyman GH
    Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients--a pilot study.
    Ferroni P; Martini F; Portarena I; Grenga I; Riondino S; La Farina F; Laudisi A; Guadagni F; Roselli M
    Support Care Cancer; 2012 Nov; 20(11):2713-20. PubMed ID: 22322591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients.
    Gonzalez-Billalabeitia E; Castellano D; Sobrevilla N; Guma J; Hervas D; Luengo MI; Aparicio J; Sanchez-Muñoz A; Mellado B; Saenz A; Valverde C; Fernandez A; Margeli M; Duran I; Fernandez S; Sastre J; Ros S; Maroto P; Manneh R; Cerezuela P; Carmona-Bayonas A; Ayala de la Peña F; Luis Aguilar J; Rivera S; García Del Muro X; Germà-Lluch JR;
    J Natl Cancer Inst; 2017 Jan; 109(4):. PubMed ID: 28122896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-O blood type is associated with an increased risk of venous thromboembolism after radical cystectomy.
    Wang JK; Boorjian SA; Frank I; Tarrell RF; Thapa P; Jacob EK; Tauscher CD; Tollefson MK
    Urology; 2014 Jan; 83(1):140-5. PubMed ID: 24139524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, Heidelberg.
    Berger AK; Zschaebitz S; Komander C; Jäger D; Haag GM
    World J Gastroenterol; 2015 Apr; 21(16):4911-8. PubMed ID: 25945004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of venous thromboembolism in the setting of hematopoietic cell transplantation.
    O'Hara VJ; Miller T; Mehta R; Swartzendruber E; Kiel PJ
    Am J Ther; 2014; 21(1):15-9. PubMed ID: 24061558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.